title: Identification of genes that modify ataxin-1-induced neurodegeneration.
abstract: A growing number of human neurodegenerative diseases result from the expansion of a glutamine repeat in the protein that causes the disease. Spinocerebellar ataxia type 1 (SCA1) is one such disease-caused by expansion of a polyglutamine tract in the protein ataxin-1. To elucidate the genetic pathways and molecular mechanisms underlying neuronal degeneration in this group of diseases, we have created a model system for SCA1 by expressing the full-length human SCA1 gene in Drosophila. Here we show that high levels of wild-type ataxin-1 can cause degenerative phenotypes similar to those caused by the expanded protein. We conducted genetic screens to identify genes that modify SCA1-induced neurodegeneration. Several modifiers highlight the role of protein folding and protein clearance in the development of SCA1. Furthermore, new mechanisms of polyglutamine pathogenesis were revealed by the discovery of modifiers that are involved in RNA processing, transcriptional regulation and cellular detoxification. These findings may be relevant to the treatment of polyglutamine diseases and, perhaps, to other neurodegenerative diseases, such as Alzheimer's and Parkinson's disease.
authors.affiliation: Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030, USA.
authors.forename: P
authors.initials: P
authors.lastname: Fernandez-Funez
authors.forename: M L
authors.initials: ML
authors.lastname: Nino-Rosales
authors.forename: B
authors.initials: B
authors.lastname: de Gouyon
authors.forename: W C
authors.initials: WC
authors.lastname: She
authors.forename: J M
authors.initials: JM
authors.lastname: Luchak
authors.forename: P
authors.initials: P
authors.lastname: Martinez
authors.forename: E
authors.initials: E
authors.lastname: Turiegano
authors.forename: J
authors.initials: J
authors.lastname: Benito
authors.forename: M
authors.initials: M
authors.lastname: Capovilla
authors.forename: P J
authors.initials: PJ
authors.lastname: Skinner
authors.forename: A
authors.initials: A
authors.lastname: McCall
authors.forename: I
authors.initials: I
authors.lastname: Canal
authors.forename: H T
authors.initials: HT
authors.lastname: Orr
authors.forename: H Y
authors.initials: HY
authors.lastname: Zoghbi
authors.forename: J
authors.initials: J
authors.lastname: Botas
mesh_terms: D000818:Animals; D030801:Animals, Genetically Modified; D000067696:Ataxin-1; D000067528:Ataxins; D004195:Disease Models, Animal; D004330:Drosophila; D005260:Female; D018869:Heat-Shock Response / Q000235:genetics; D006801:Humans; D002479:Inclusion Bodies; D008297:Male; D009410:Nerve Degeneration / Q000235:genetics*; D009419:Nerve Tissue Proteins / Q000235:genetics*; D019636:Neurodegenerative Diseases / Q000235:genetics* / Q000473:pathology; D009687:Nuclear Proteins / Q000235:genetics*; D010641:Phenotype; D017510:Protein Folding; D012160:Retina / Q000378:metabolism; D020754:Spinocerebellar Ataxias / Q000235:genetics* / Q000473:pathology
chemical_list: C000593749:ATXN1 protein, human; D000067696:Ataxin-1; D000067528:Ataxins; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins